Maturation and upregulation of functions of murine dendritic cells (DCs) under the influence of purified aromatic-turmerone (AR)

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 10, 2012, Pages 1416-1424

  Tan, Yonggang ^a   Meng, Yiming ^a   Zhang, Heying ^a   Sun, Cheng ^a   Wang, Qiushi ^a   Yang, Xianghong ^a   Zheng, Wei ^a   Zhou, Huawei ^a   Fengping, Shan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

AR; BMDCs; Maturation; Modulation

Indexed keywords

EID: 84868267185     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.21526     Document Type: Article

References (35)

1. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57:1-7; PMID:2062949; http://dx.doi.org/10.1055/s-2006-960004.
2. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis 2007; 28:1765-73; PMID:17522064; http://dx.doi.org/10.1093/carcin/bgm123.
3. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327:656- 61; PMID:20133564; http://dx.doi.org/10.1126/science.1178331.
4. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 2007; 219:143-56; PMID:17850487; http://dx.doi.org/10.1111/ j.1600-065X.2007.00552.x.
5. Muth S, Schutze K, Schild H, Probst HC. Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proc Natl Acad Sci U S A 2012; 109:9059-64; PMID:22615402; http://dx.doi.org/10.1073/pnas.1110620109.
6. Agrawal A, Gupta S. Impact of aging on dendritic cell functions in humans. Ageing Res Rev 2011; 10:336- 45; PMID:20619360; http://dx.doi.org/10. 1016/j.arr.2010.06.004.
7. Donald A, Fitch FW. The road to the discovery of dendritic cells, a tribute to Ralph Steinman. Cell Immunol 2012; 2012: 273:95-8:PMID: 22326169
8. Jayaprakasha GK, Negi PS, Anandharamakrishnan C, Sakariah KK. Chemical composition of turmeric oil-a byproduct from turmeric oleoresin industry and its inhibitory activity against different fungi. Z Naturforsch C 2001; 56:40-4; PMID:11302211.
9. Jayaprakasha GK, Jaganmohan Rao L, Sakariah KK. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem 2006; 2005:720-4; http://dx.doi.org/10.1016/j.foodchem.2005.06.037.
10. Singh G, Kapoor IPS, Singh P, de Heluani CS, de Lampasona MP, Catalan CA. Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food Chem Toxicol 2010; 48:1026- 31; PMID:20096323; http://dx.doi.org/10.1016/j.fct.2010.01.015.
11. Balaji S, Chempakam B. Toxicity prediction of compounds from turmeric (Curcuma longa L). Food Chem Toxicol 2010; 48:2951-9; PMID:20667459; http:// dx.doi.org/10.1016/j.fct.2010.07.032.
12. Sindhu S, Chempakam B, Leela NK, Suseela Bhai R. Chemoprevention by essential oil of turmeric leaves (Curcuma longa L.) on the growth of Aspergillus flavus and aflatoxin production. Food Chem Toxicol 2011; 49:1188-92; PMID:21354246; http://dx.doi.org/10.1016/j.fct.2011.02.014.
13. Martin RC, Aiyer HS, Malik D, Li Y. Effect on proinflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects. Food Chem Toxicol 2012; 50:227-31; PMID:22079310; http://dx.doi.org/10.1016/j.fct.2011.10.070.
14. Ling J, Wei B, Lv G, Ji H, Li S. Anti-hyperlipidaemic and antioxidant effects of turmeric oil in hyperlipidaemic rats. Food Chem 2012; 130:229-35; http://dx.doi.org/10.1016/j.foodchem.2011.07.039.
15. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 2002; 34:37-46; PMID:14764309; http://dx.doi.org/10.1016/S0167-4943(01)00194-7.
16. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem 1999; 47:4297-300; PMID:10552805; http:// dx.doi.org/10.1021/jf990308d.
17. Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Chemistry and biological activities of C. longa. Trends Food Sci Technol 2005; 16:533-48; http://dx.doi.org/10.1016/j.tifs.2005.08.006.
18. Prakash P, Misra A, Surin WR, Jain M, Bhatta RS, Pal R, et al. Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res 2011; 127:111- 8; PMID:21144557; http://dx.doi.org/10.1016/j.thromres.2010.11.007.
19. Aratanechemuge Y, Komiya T, Moteki H, Katsuzaki H, Imai K, Hibasami H. Selective induction of apoptosis by ar-turmerone isolated from turmeric (Curcuma longa L) in two human leukemia cell lines, but not in human stomach cancer cell line. Int J Mol Med 2002; 9:481-4; PMID:11956652.
20. Ji M, Choi J, Lee J, Lee Y. Induction of apoptosis by ar-turmerone on various cell lines. Int J Mol Med 2004; 14:253-6; PMID:15254774.
21. Park SY, Jin ML, Kim YH. Aromatic-turmerone inhibits a-MSH and IBMX-induced melanogenesis by inactivating CREB and MITF signaling pathways. Arch Dermatol Res 2011; 303:737-44; PMID:21660443; http://dx.doi.org/10.1007/ s00403-011-1155-7.
22. Jayaprakasha GK, Jena BS, Negi PS, Sakariah KK. Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production. Z Naturforsch C 2002; 57:828-35; PMID:12440720.
23. Lee HS. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour Technol 2006; 97:1372-6; PMID:16112857; http://dx.doi.org/10.1016/j.biortech.2005.07.006.
24. Yue GGL, Chan BCL, Hon P-M, Lee MYH, Fung K-P, Leung P-C, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol 2010; 48:2011-20; PMID:20438793; http://dx.doi.org/10.1016/j.fct.2010.04.039.
25. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588.
26. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90:3245-87; PMID:9345009.
27. Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006; 107:2613-8; PMID:16317096; http://dx.doi.org/10.1182/blood-2005-07-2965.
28. Schuler G. Dendritic cells: indispensable? Cancer J 2011; 17:337-42; PMID:21952284; http://dx.doi.org/10.1097/PPO.0b013e3182350077.
29. Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012; 12:101-13.; PMID:22273772; http://dx.doi.org/10. 1038/nri3149 30. Blanco PA, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008; 19:41-52; PMID:18258476; http://dx.doi.org/10.1016/j.cytogfr. 2007.10.004.
30. Morva A, Lemoine S, Achour A, Pers JO, Youinou P, Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012; 119:106-14; PMID:22067387; http://dx.doi.org/10.1182/blood-2011-06-360768.
31. Nagato K, Motohashi S, Ishibashi F, Okita K, Yamasaki K, Moriya Y, et al. Accumulation of activated invariant natural killer T cells in the tumor microenvironment after 〈-Galactosylceramide-Pulsed antigen presenting cells. J Clin Immunol 2012;:; PMID:22534863; http://dx.doi.org/10.1007/s10875- 012-9697-9.
32. Park MH, Lee JS, Yoon JH. High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J Surg Oncol 2012; PMID:22422195; http:// dx.doi.org/10.1002/jso.23095.
33. Reichardt VL, Brossart P, Kanz L. Dendritic cells in vaccination therapies of human malignant disease. Blood Rev 2004; 18:235-43; PMID:15501552; http:// dx.doi.org/10.1016/j.blre.2003.12.001.
34. Ullricha E, Menarda C, Flamenta C, Termea M, Mignota G, Bonmorta M, et al. Dendritic cells and innate defense against tumor cells. Cytokine Growth Factor Rev 2008; 1:79-92; http://dx.doi.org/10.1016/j.cytogfr.2007.10.009.
35. Ballestreroa A, Boya D, Morana E, Cirmenaa G, Brossartb P, Nencionia A. Immunotherapy with dendriticcells for cancer. Adv Drug Deliv Rev 2008; 2:173- 83; http://dx.doi.org/10.1016/j.addr.2007.08.026.